List of Oracle Siebel CTMS Customers
Austin, 78741, TX,
United States
Since 2010, our global team of researchers has been studying Oracle Siebel CTMS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Oracle Siebel CTMS for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Oracle Siebel CTMS for Clinical Trial Management include: BeiGene, Ltd., a United States based Life Sciences organisation with 9000 employees and revenues of $1.18 billion, Novotech, a Australia based Life Sciences organisation with 2500 employees and revenues of $500.0 million, Duke Clinical Research Institute, a United States based Healthcare organisation with 1300 employees and revenues of $173.0 million and many others.
Contact us if you need a completed and verified list of companies using Oracle Siebel CTMS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Oracle Siebel CTMS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BeiGene, Ltd. | Life Sciences | 9000 | $1.2B | United States | Oracle | Oracle Siebel CTMS | Clinical Trial Management | 2019 | n/a | In 2019, BeiGene, Ltd. implemented Oracle Siebel CTMS for Clinical Trial Management to centralize clinical operations, site management, and study oversight across its global clinical programs. The implementation targeted coverage across Asia Pacific and the US, establishing a single platform for study governance and operational consistency. Oracle Siebel CTMS was configured to support core Clinical Trial Management workflows including study management, site management, monitoring workflows, enrollment tracking, regulatory document management, and operational reporting and dashboards. Configuration emphasis was on study and site hierarchies, monitoring visit scheduling, and role based access to support clinical operations and oversight functions. The deployment was structured as a centralized CTMS instance to provide cross program visibility and to standardize site management and oversight processes across regions. The architecture supported consolidated data visibility for clinical teams and sponsors, enabling unified study oversight across Asia Pacific and US clinical sites. Oracle's customer story explicitly highlights operational efficiency and improved data visibility as outcomes of the BeiGene Oracle Siebel CTMS implementation, reinforcing governance improvements in study oversight and site management workflows. Operational governance focused on standardized monitoring cadence and centralized study controls to improve transparency and coordination across clinical functions. | |
 |
Duke Clinical Research Institute | Healthcare | 1300 | $173M | United States | Oracle | Oracle Siebel CTMS | Clinical Trial Management | 2003 | n/a | In 2003 the Duke Clinical Research Institute purchased Oracle Siebel CTMS and initiated a Clinical Trial Management implementation. The institute ran pilot projects in 2005 and 2006 and adopted Oracle Siebel CTMS for all new projects beginning in 2007 to standardize clinical operations and improve trial management. Oracle Siebel CTMS was deployed to support core clinical operations, delivering trial management and site coordination capabilities. Functional configuration emphasized study lifecycle tracking, subject enrollment monitoring, protocol and document management, centralized study records, and operational workflow automation consistent with Clinical Trial Management systems. The Applied Clinical Trials case study notes that the CTMS was integrated with other clinical systems, and DCRI aligned CTMS processes with clinical operations and site coordination teams. Rollout followed a phased approach of pilots then default adoption for new studies starting in 2007, establishing standardized operating procedures and centralized governance for trial setup and site management under the Oracle Siebel CTMS Clinical Trial Management deployment. | |
 |
Novotech | Life Sciences | 2500 | $500M | Australia | Oracle | Oracle Siebel CTMS | Clinical Trial Management | 2015 | n/a | In 2015, Novotech implemented Oracle Siebel CTMS to provide Clinical Trial Management capabilities for sponsor trials across the Asia Pacific region. Novotech, an Asia Pacific CRO headquartered in Australia, lists Oracle Siebel CTMS as part of its technology stack and uses the application to centralize clinical operations and site management across APAC. The deployment emphasized core CTMS functional modules, including study and site management, investigator and contact records, study planning and tracking, enrollment and visit scheduling, monitoring visit workflows, and centralized document management. Configuration work focused on protocol level study records, workflow driven monitoring and site activation processes, and role based access controls to support clinical operations and site management teams. Novotech describes integrations between Oracle Siebel CTMS and other trial systems to enable cross system data exchanges and orchestration of trial workflows. Integrations are oriented around trial operational flows and include interfaces with external trial systems such as electronic data capture platforms, trial master file repositories, safety reporting feeds, and sponsor portals, supporting multi country and multi site studies across the APAC operational footprint. Operational governance for the implementation centered on regional CTMS governance and standardized procedures for study setup, monitoring, and site management, with training aligned to study managers and clinical research associate workflows. The narrative positions Novotech Oracle Siebel CTMS Clinical Trial Management as the platform linking sponsor facing operational functions to other clinical systems in the APAC region. |
Buyer Intent: Companies Evaluating Oracle Siebel CTMS
- Vertex Pharmaceuticals, a United States based Life Sciences organization with 5400 Employees
- Columbia University, a United States based Education company with 21489 Employees
- Tandym Group, a United States based Professional Services organization with 300 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||